氢氧混合气在改善免疫力方面的作用

摘要：氢氧混合气在治疗新冠肺炎中的应用氢氧混合气曾经写入新冠肺炎诊疗方案中，但其有效性的证据仍然比较薄弱，因此仍然需要进一步研究，特别是采用严格的多中心双盲安慰剂对照临床试验，只有高质量高级别...

氢氧混合气曾经写入新冠肺炎诊疗方案中，但其有效性的证据仍然比较薄弱，因此仍然需要进一步研究，特别是采用严格的多中心双盲安慰剂对照临床试验，只有高质量高级别的临床研究证据，才能作为证明氢气在疾病治疗有效性方面的基础。这也是氢气医学同行们早就达成的共识。关于氢气用于COVID-19患者治疗，上海多家医院的多中心研究结果最近发表。这里摘要翻译介绍给大家，英文摘要同时提供。

Shi M M, Chen Y T, Wang X D, et al. The efficacy of hydrogen/oxygen therapy favored the recovery of omicron SARS-CoV-2 variant infection: results of a multicenter, randomized, controlled trial[J]. Journal of Clinical Biochemistry and Nutrition, 2023: 23-32.

临床研究发现，氢/氧混合吸入对于改善COVID-19患者辅助治疗中的呼吸症状有益。我们旨在探索氢/氧疗法在促进Omicron SARS-CoV-2变体感染恢复方面的有效性。共有64名患者被随机分配接受氢/氧吸入（32名患者）和氧气吸入（32名患者）。氢/氧组中Omicron的平均脱落持续时间比氧气组短。Omicron的累积阴性转化率趋势在第三天后逐渐增加。氢/氧组中的IL-6水平较基线降低了22.8%。在接受氢/氧混合气体吸入后，氢/氧组中的淋巴细胞计数在第3天增加到基线的61.1%。氢/氧组中有更多患者的肺部病变得到解决。我们的研究表明，分子氢在治疗COVID-19患者方面具有有益的趋势，这可能为COVID-19患者的辅助治疗提供一种有前景的解决方案。

氢氧混合气治疗心冠.png

Clinical studies had found that hydrogen/oxygen mixed inhalation was beneficial to ameliorate the respiratory symptoms in the adjuvant treatment of patients with COVID-19. We aimed to explore the efficacy of hydrogen/oxygen therapy in favoring the recovery of Omicron SARS-CoV-2 variant infection. There were 64 patients WHO randomly assigned to receive hydrogen/oxygen inhalation (32 patients) and oxygen inhalation (32 patients). The average shedding duration of Omicron in hydrogen/oxygen group was shorter than oxygen group. The trend of cumulative negative conversion rate of Omicron increased gradually after the third day. The IL-6 levels in hydrogen/oxygen group decreased by 22.8% compared with the baseline. After hydrogen/oxygen mixed gas inhalation, the lymphocyte count increased to 61.1% of the baseline on the 3rd day in the hydrogen/oxygen group. More patients in the hydrogen/oxygen group had resolution of pulmonary lesions. Our study showed the beneficial trends of molecular hydrogen in treating patients with COVID-19, which may offer a prospective solution to adjuvant therapy for COVID-19 Patients.

该论文作者主要来自上海交通大学附属瑞金医院、复旦大学附属中山医院和同济大学附属医院等上海多家医疗机构。

复合小分子肽主要成分：人参（五年以下人工种植）、牛骨髓肽、海洋鱼低聚肽、牡蛎肽、地龙蛋白肽、苦瓜肽、纳豆粉、菊粉